19 hrs ago | Fool.com
After four follow-on stock offerings in the last three years -- the number of shares outstanding has increased a whopping 57.8% since the end of 2005 -- it's nice to see that Rule Breakers pick Vertex Pharmaceuticals has a plan to raise some cash that won't dilute its shareholders.
Yesterday | Medical News Today
NICE Upholds GlaxoSmithKline Appeal For Advanced Breast Cancer Treatment, Tyverb
Main Category: Breast Cancer Also Included In: Cancer / Oncology Article Date: 10 Jul 2009 - 1:00 PDT The National Institute for Health and Clinical Excellence announced that, following GlaxoSmithKline's appeal, it will reconsider the submission for Tyverb , a treatment for an aggressive form of advanced breast cancer .1 GSK is pleased that NICE's ...
Mahindra Satyam signs multi-million dollar deal with GSK
New Delhi : Mahindra Satyam on Thursday said it has signed a five-year multi-million dollar deal with UK-based GlaxoSmithKline to provide SAP and other critical systems support.
WHO OKs Cervical Cancer Vaccine Cervarix
The World Health Organization has approved a cervical cancer vaccine made by GlaxoSmithKline, meaning U.N. agencies and partners can now officially buy millions of doses of the vaccine for poor countries worldwide.
FDA and News Updates for GlaxoSmithKline
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has new updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions as well as news updates and reports which may have an impact on each of the ...
WHO says no indication of resistant flu spread
Tamiflu-resistant H1N1 flu does not appear to be spreading in a sustained or worrisome way, a World Health Organisation official said yesterday.
GlaxoSmithKline says study shows Cervarix vaccine could...
Drugmaker GlaxoSmithKline PLC said Tuesday a study shows its human papillomavirus vaccine Cervarix was effective against the types of HPV that are most likely to cause cervical cancer, but also fought other strains of the disease.
GlaxoSmithKline merger hits second delay
The deal to create the world's most powerful drugs group through the merger of Glaxo Wellcome and SmithKline Beecham was delayed for a second time yesterday, amid unexpected concerns surrounding the companies' dominance in anti-smoking drugs.
Lawsuit Abuse Fortnightly #8-12
The plaintiffs' trial bar hopes to take a bite out of makers of denture cream, alleging the product causes neurological problems due to zinc buildup in persons using it.
Warning: Quit-smoking drugs can kill ... but they're still on sale here
Two drugs to help smokers kick the habit will continue to be sold in Hong Kong despite claims they may trigger depression or induce suicidal thoughts.
Phase Forward, GSK sign multi-million dollar deal
GlaxoSmithKline has signed a multi-year, multi-million dollar contract with Waltham-based Phase Forward Inc.
FDA requires Pfizer's smoking cessation drug Chantix, Glaxo's Zyban to carry stronger warning
The Food and Drug Administration will require two smoking-cessation drugs, Chantix and Zyban, to carry the agency's strongest safety warning over side effects including depression and suicidal thoughts.
Phase Forward Customer GlaxoSmithKline Signs Multi-Year Agreements
Phase Forward , a leading provider of data management solutions for clinical trials and drug safety, today announced that GlaxoSmithKline has signed multi-year, multi-million dollar contracts covering Licensing and Study Support Services.
Pharma companies on standby for flu jabs
GlaxoSmithKline and Roche, two major pharmaceutical companies, have had sizeable sales increases during the first quarter of 2009.
The hidden cost of free vaccines
Giving products away free, from browsers to newspaper articles, is commonplace in the technology and media industries.
Pharmaceutical Stocks Get Boost from Swine Flu?
Pandemic spells profit for pharmaceutical giants like Sanofi-Aventis , GlaxoSmithKline and Merck who represent the top three producers of vaccines to treat H1N1 or swine flu.
GSK, Chroma Form Macrophage Alliance
GlaxoSmithKline and Chroma Therapeutics have formed a collaboration to develop macrophage-targeted compounds using Chroma's proprietary esterase-sensitive motif technology, which adds amino acid esters to compounds with the aim of targeting the compounds to specific cells in the inflammatory disease process.
GSK to develop inflammatory disease treatments with Chroma Therapeutics
LONDON British drug maker GlaxoSmithKline will collaborate with a fellow British pharmaceutical company to develop treatments for such inflammatory diseases as rheumatoid arthritis.
FDA rejects GlaxoSmithKline nausea, vomiting drug
The U.S. Food and Drug Administration has rejected GlaxoSmithKline PLC's application to approve an experimental drug for nausea and vomiting.
GlaxoSmithKline Opens $600million Vaccine Plant In Singapore
GlaxoSmithKline Opens $600million Vaccine Plant In Singapore >> Posted By noohinter 3 hours, 17 minutes ago in Business & Finance Singapore's pharmaceutical industry has moved into higher gear, with the opening of a state-of-the-art vaccine plant.